Background
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq].
Product Information
Source: E coli; insect cells; or mammalian cells: 293, CHO
| Purity: Greater than 95% as determined by RP-HPLC or SDS-PAGE analysis.
|
Purification Method: FPLC
| |
Gene/Protein Information
Gene Name: ACVR1
| Gene Symbol: ACTRI, ACVRLK2, ALK2, FOP, SKR1
|
Gene Name Synonyms: ACTRI, ACVRLK2, ALK2, FOP, SKR1
| NCBI Acc#: NM_001105
|
SwissProt: Q6ZVS7
| Chromosomal Location: 2q23-q24
|
Availability
Custom Expression: 4 to 10 weeks
